Table 1.
Baseline characteristics
| dCRT n = 36, (%) | nCRT n = 72, (%) | P-value | |
|---|---|---|---|
| Gender: male | 27 (75) | 49 (68) | 0.5 |
| Age (mean, SD) | 67.9 (7.6) | 66.4 (7.3) | 0.3 |
| ASA | 0.2 | ||
| I | 3 (8) | 4 (6) | |
| II | 21 (58) | 53 (74) | |
| III | 12 (33) | 15 (21) | |
| cT-stage | <0.01 | ||
| 2 | 5 (14) | 16 (22) | |
| 3 | 23 (64) | 55 (76) | |
| 4 | 8 (22) | 1 (1) | |
| cN-stage | 0.84 | ||
| 0 | 13 (36) | 26 (36) | |
| 1 | 12 (33) | 38 (39) | |
| 2 | 10 (28) | 15 (21) | |
| 3 | 1 (3) | 3 (4) | |
| cM-stage | 0.33 | ||
| 0 | 35 (97) | 72 (100) | |
| 1 | 1 (3) | 0 (0) | |
| Tumor type: | >0.90 | ||
| Adenocarcinoma | 17 (47) | 34 (47) | |
| Squamous cell carcinoma | 19 (53) | 38 (53) | |
| Days from CRT to surgery (median, range) | 64.5 (51–97) | 48.0 (41–54) | <0.01 |
| Type of surgery | 0.8 | ||
| Transhiatal | 18 (50) | 36 (50) | |
| Transthoracal (open) | 13 (36) | 29 (40) | |
| Transthoracal (laparoscopic) | 5 (14) | 7 (10) | |
| Year of surgery | >0.90 | ||
| 2012–2014 | 8 (22) | 16 (22) | |
| 2015–2017 | 20 (56) | 40 (56) | |
| 2018–2020 | 8 (22) | 16 (22) | |
| Surgery time (minutes, median, range) | 223 (100–360) | 216 (120–440) | 0.5 |
| Blood loss (ml, median, range) | 450 (95–1400) | 350 (30–1900) | 0.09 |